164 related articles for article (PubMed ID: 31768798)
1. Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma.
Ishikawa M; Hayashi H; Sakamoto N; Tanaka S; Nishihara H
Med Oncol; 2019 Nov; 37(1):10. PubMed ID: 31768798
[TBL] [Abstract][Full Text] [Related]
2. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
3. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
Ge S; Li B; Li Y; Li Z; Liu Z; Chen Z; Wu J; Gao J; Shen L
Am J Cancer Res; 2017; 7(7):1540-1553. PubMed ID: 28744403
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis by next generation sequencing of gastric type dysplasia occurring in hyperplastic polyps of the stomach: Mutations in gastric hyperplastic polyps.
Salomao M; Luna AM; Sepulveda JL; Sepulveda AR
Exp Mol Pathol; 2015 Dec; 99(3):468-73. PubMed ID: 26325218
[TBL] [Abstract][Full Text] [Related]
8. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
10. Association of Helicobacter pylori and diffuse type gastric cancer.
Handa Y; Saitoh T; Kawaguchi M; Misaka R; Ohno H; Tsai CR; Tani Y; Tsurui M; Yoshida H; Morita S; Midorikawa S; Sanji T
J Gastroenterol; 1996 Nov; 31 Suppl 9():29-32. PubMed ID: 8959514
[TBL] [Abstract][Full Text] [Related]
11. A novel gene, GCRG224, is differentially expressed in human gastric mucosa.
Wang GS; Wang MW; Wu BY; You WD; Yang XY
World J Gastroenterol; 2003 Jan; 9(1):30-4. PubMed ID: 12508346
[TBL] [Abstract][Full Text] [Related]
12. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
13. Alterations in mucin type: an indicator for suspicion of malignant gastric transformation.
Cheah PL; Ramachandran K
Malays J Pathol; 1994 Jun; 16(1):39-42. PubMed ID: 16329574
[TBL] [Abstract][Full Text] [Related]
14. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P
Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
18. Actionable gene-based classification toward precision medicine in gastric cancer.
Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
[TBL] [Abstract][Full Text] [Related]
19. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
[TBL] [Abstract][Full Text] [Related]
20. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
Yoshida T; Yamaguchi T; Maekawa S; Takano S; Kuno T; Tanaka K; Iwamoto F; Tsukui Y; Kobayashi S; Asakawa Y; Shindo H; Fukasawa M; Nakayama Y; Inoue T; Uetake T; Ohtaka M; Sato T; Mochizuki K; Enomoto N
Gastric Cancer; 2019 Jul; 22(4):742-750. PubMed ID: 30756200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
